JP2025503513A5 - - Google Patents
Info
- Publication number
- JP2025503513A5 JP2025503513A5 JP2024538668A JP2024538668A JP2025503513A5 JP 2025503513 A5 JP2025503513 A5 JP 2025503513A5 JP 2024538668 A JP2024538668 A JP 2024538668A JP 2024538668 A JP2024538668 A JP 2024538668A JP 2025503513 A5 JP2025503513 A5 JP 2025503513A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- antibody
- sequence
- sequence shown
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111639610.2 | 2021-12-29 | ||
| CN202111639610 | 2021-12-29 | ||
| PCT/CN2022/142626 WO2023125611A1 (zh) | 2021-12-29 | 2022-12-28 | 靶向cd3的抗体及多特异性抗体及其用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503513A JP2025503513A (ja) | 2025-02-04 |
| JP2025503513A5 true JP2025503513A5 (https=) | 2026-02-17 |
Family
ID=86997950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024538668A Pending JP2025503513A (ja) | 2021-12-29 | 2022-12-28 | Ｃｄ３を標的にする抗体、多特異性抗体、およびその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250059278A1 (https=) |
| EP (1) | EP4458861A1 (https=) |
| JP (1) | JP2025503513A (https=) |
| CN (1) | CN118591561A (https=) |
| WO (1) | WO2023125611A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI796283B (zh) * | 2015-07-31 | 2023-03-21 | 德商安美基研究（慕尼黑）公司 | Ｍｓｌｎ及ｃｄ３抗體構築體 |
| WO2018209304A1 (en) * | 2017-05-12 | 2018-11-15 | Harpoon Therapeutics, Inc. | Msln targeting trispecific proteins and methods of use |
| CN110229232B (zh) * | 2019-06-19 | 2020-05-19 | 北京智仁美博生物科技有限公司 | 双特异性抗体及其用途 |
| CN111349163B (zh) * | 2020-02-05 | 2024-07-16 | 北京智仁美博生物科技有限公司 | 针对cd123的单克隆抗体 |
-
2022
- 2022-12-28 EP EP22914863.0A patent/EP4458861A1/en active Pending
- 2022-12-28 JP JP2024538668A patent/JP2025503513A/ja active Pending
- 2022-12-28 US US18/723,721 patent/US20250059278A1/en active Pending
- 2022-12-28 CN CN202280085681.9A patent/CN118591561A/zh active Pending
- 2022-12-28 WO PCT/CN2022/142626 patent/WO2023125611A1/zh not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022058345A5 (https=) | ||
| JP2025503513A5 (https=) | ||
| Jain et al. | Engineering antibodies for clinical applications | |
| KR102340832B1 (ko) | 항 pd-1 항체 및 그의 용도 | |
| CA2987118C (en) | A pdl-1 antibody, pharmaceutical composition thereof and use thereof | |
| JP2022515318A5 (https=) | ||
| JP2020501531A5 (https=) | ||
| JP2025078629A (ja) | 多重特異性抗体 | |
| JP2021534802A5 (https=) | ||
| WO2022136647A1 (en) | Human ccr8 binders | |
| JP7611931B2 (ja) | ガイダンス及びナビゲーションコントロール（ｇｎｃ）抗体様タンパク質、その製造方法及び使用方法 | |
| JP2018532766A5 (https=) | ||
| JP2017519759A5 (https=) | ||
| CA3196809A1 (en) | Combination treatment | |
| US20250034273A1 (en) | Composition of multispecific antibodies targeting cadherin-17-expressing tumors and method of making and using thereof | |
| CN116041530A (zh) | 多特异性抗体及其制备和使用方法 | |
| JP2024509018A5 (https=) | ||
| WO2022143801A1 (en) | Multispecific antigen binding proteins | |
| CA3074524A1 (en) | Novel anti-cd19 antibodies | |
| Dhimolea et al. | World bispecific antibody summit, September 27–28, 2011, Boston, MA | |
| US20230002488A1 (en) | Guidance and navigation control proteins and method of making and using thereof | |
| Accardi et al. | Antibodies in single-chain format against tumour-associated antigens: present and future applications | |
| WO2021041300A2 (en) | Bispecific antibodies and uses thereof | |
| JP7641292B2 (ja) | 抗ｃｄ１９抗体、その使用方法及び製造方法 | |
| Kafil et al. | Immunotargeting and therapy of cancer by advanced multivalence antibody scaffolds |